Combination therapies for Type 1 diabetes: why not now?

被引：1
|
作者：
von Herrath, Matthias [1 ]
机构：
[1] La Jolla Inst Allergy & Immunol, Ctr Type Diabet Res 1, La Jolla, CA 92037 USA
来源：
IMMUNOTHERAPY | 2010年 / 2卷 / 03期
关键词：
ANTI-CD3; MONOCLONAL-ANTIBODY; STEM-CELL TRANSPLANTATION; INSULIN; ONSET; AUTOIMMUNITY; MELLITUS; REMISSION; REVERSAL; MICE;
D O I：
10.2217/IMT.10.23
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：289 / 291
页数：3
相关论文
共 50 条
  • [41] Combination immunotherapies for type 1 diabetes mellitus
    Paolo Pozzilli
    Ernesto Maddaloni
    Raffaella Buzzetti
    Nature Reviews Endocrinology, 2015, 11 : 289 - 297
  • [42] Monogenic diabetes and type 1 diabetes mellitus: a challenging combination
    Uday, Suma
    Campbell, Fiona M.
    Cropper, Julie
    Shepherd, Maggie
    PRACTICAL DIABETES, 2014, 31 (08) : 327 - 330
  • [43] Combination molecular therapies for type 1 spinal muscular atrophy
    Harada, Yohei
    Rao, Vamshi K.
    Arya, Kapil
    Kuntz, Nancy L.
    DiDonato, Christine J.
    Napchan-Pomerantz, Galia
    Agarwal, Amit
    Stefans, Vikki
    Katsuno, Masahisa
    Veerapandiyan, Aravindhan
    MUSCLE & NERVE, 2020, 62 (04) : 550 - 554
  • [44] Prevention and treatment of diabetes in children - Now is the time to prevent type 1 diabetes
    Schatz, D
    Krischer, J
    Skyler, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02): : 495 - 498
  • [45] Islet transplantation for Type 1 diabetes: where are we now?
    Ahearn, Aaron J.
    Parekh, Justin R.
    Posselt, Andrew M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (01) : 59 - 68
  • [46] Association of Type 1 Diabetes Mellitus and Celiac Disease: Then and Now
    Ni, Jennifer
    Khosla, Chaitan
    Maahs, David M.
    JOURNAL OF PEDIATRICS, 2021, 230 : 70 - 70
  • [47] Incidence and seasonality of type 1 diabetes mellitus - What now?
    Laron, Z
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 (05): : 573 - 575
  • [48] An update on combination therapies for multiple sclerosis: where are we now?
    Sorensen, Per Soelberg
    Magyari, Melinda
    Sellebjerg, Finn
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (12) : 1173 - 1187
  • [49] Two-year outcome of a combination of weight loss therapies for type 2 diabetes
    Redmon, JB
    Kwong, CA
    Reck, KP
    Ji, H
    Raatz, SK
    Thomas, W
    Swanson, JE
    Bantle, JP
    DIABETES CARE, 2005, 28 (06) : 1311 - 1315
  • [50] Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin
    Yu, Huan
    Woo, Vincent C.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 317 - 332
12345